<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Brain Injury review &#187; ischaemic brain injury</title>
	<atom:link href="http://www.braininjuryreview.com/category/ischaemic-brain-injury/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.braininjuryreview.com</link>
	<description>All the latest information on brain injury research</description>
	<lastBuildDate>Sat, 28 Apr 2007 17:17:38 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: Reduced neutrophil activation and anti-oxidant actions.</title>
		<link>http://www.braininjuryreview.com/2007/02/10/neuroprotective-effects-of-pmc-a-potent-alpha-tocopherol-derivative-in-brain-ischemia-reperfusion-reduced-neutrophil-activation-and-anti-oxidant-actions/</link>
		<comments>http://www.braininjuryreview.com/2007/02/10/neuroprotective-effects-of-pmc-a-potent-alpha-tocopherol-derivative-in-brain-ischemia-reperfusion-reduced-neutrophil-activation-and-anti-oxidant-actions/#comments</comments>
		<pubDate>Sat, 10 Feb 2007 19:23:43 +0000</pubDate>
		<dc:creator>Deano</dc:creator>
				<category><![CDATA[ischaemic brain injury]]></category>

		<guid isPermaLink="false">http://www.braininjuryreview.com/2007/02/10/neuroprotective-effects-of-pmc-a-potent-alpha-tocopherol-derivative-in-brain-ischemia-reperfusion-reduced-neutrophil-activation-and-anti-oxidant-actions/</guid>
		<description><![CDATA[This article by G Hsiao and colleagues from Taipai takes a look at the antioxidant properties of PMC and its effects upon cerebral artery ischemia. 2,2,5,7,8-Pentamethyl-6-hydroxychromane (PMC) is the most potent analogue of alpha-tocopherol for anti-oxidation. It is more hydrophilic than other alpha-tocopherol derivatives and has potent free radical-scavenging activity. In the present study, PMC [...]]]></description>
		<wfw:commentRss>http://www.braininjuryreview.com/2007/02/10/neuroprotective-effects-of-pmc-a-potent-alpha-tocopherol-derivative-in-brain-ischemia-reperfusion-reduced-neutrophil-activation-and-anti-oxidant-actions/feed/</wfw:commentRss>
		<slash:comments>1745</slash:comments>
		</item>
		<item>
		<title>Ischemic preconditioning in the brain.</title>
		<link>http://www.braininjuryreview.com/2006/10/06/ischemic-preconditioning-in-the-brain/</link>
		<comments>http://www.braininjuryreview.com/2006/10/06/ischemic-preconditioning-in-the-brain/#comments</comments>
		<pubDate>Fri, 06 Oct 2006 21:03:25 +0000</pubDate>
		<dc:creator>Deano</dc:creator>
				<category><![CDATA[ischaemic brain injury]]></category>

		<guid isPermaLink="false">http://www.braininjuryreview.com/2006/10/06/ischemic-preconditioning-in-the-brain/</guid>
		<description><![CDATA[by Davis and Patel PURPOSE OF REVIEW: Brain ischemia is responsible for significant morbidity and mortality associated with cardiovascular surgery, and is the end result of multiple disease states, including cardiac arrest, stroke, and traumatic brain injury. Despite significant resources dedicated to developing neuroprotective strategies, little progress has been made in this regard. Neuronal ischemic [...]]]></description>
		<wfw:commentRss>http://www.braininjuryreview.com/2006/10/06/ischemic-preconditioning-in-the-brain/feed/</wfw:commentRss>
		<slash:comments>1859</slash:comments>
		</item>
		<item>
		<title>Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.</title>
		<link>http://www.braininjuryreview.com/2006/05/15/pretreatment-with-recombined-human-erythropoietin-attenuates-ischemia-reperfusion-induced-lung-injury-in-rats/</link>
		<comments>http://www.braininjuryreview.com/2006/05/15/pretreatment-with-recombined-human-erythropoietin-attenuates-ischemia-reperfusion-induced-lung-injury-in-rats/#comments</comments>
		<pubDate>Mon, 15 May 2006 17:49:02 +0000</pubDate>
		<dc:creator>Deano</dc:creator>
				<category><![CDATA[ischaemic brain injury]]></category>

		<guid isPermaLink="false">http://www.braininjuryreview.com/2006/05/15/pretreatment-with-recombined-human-erythropoietin-attenuates-ischemia-reperfusion-induced-lung-injury-in-rats/</guid>
		<description><![CDATA[This article is from H. Wu and friends at the Jingling hospital within Nanjing University in China. it is published in the European Journal of cardio-throrac surgury. Objective: Based on the findings that erythropoietin has been proved to be a multiple functional cytokine to attenuate ischemia-reperfusion (I/R) injury in various organs such as brain, heart, [...]]]></description>
		<wfw:commentRss>http://www.braininjuryreview.com/2006/05/15/pretreatment-with-recombined-human-erythropoietin-attenuates-ischemia-reperfusion-induced-lung-injury-in-rats/feed/</wfw:commentRss>
		<slash:comments>1409</slash:comments>
		</item>
	</channel>
</rss>

